Evidence map›Paper›PMID 36057657›Full record

ArticleScientific reports2022

Measuring concerns about the COVID-19 vaccine among Japanese internet users through search queries.

Makoto Uehara, Sumio Fujita, Nobuyuki Shimizu, Kongmeng Liew, Shoko Wakamiya, Eiji Aramaki

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Makoto UeharaNara Institute of Science and Technology (NAIST), Nara, Japan.
Sumio FujitaYahoo Japan Corporation, Tokyo, Japan.
Nobuyuki ShimizuYahoo Japan Corporation, Tokyo, Japan.
Kongmeng LiewNara Institute of Science and Technology (NAIST), Nara, Japan.
Shoko WakamiyaNara Institute of Science and Technology (NAIST), Nara, Japan.
Eiji AramakiNara Institute of Science and Technology (NAIST), Nara, Japan. aramaki@is.naist.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing availability of the COVID-19 vaccines, vaccination has been rapidly promoted globally as a countermeasure against the spread of COVID-19. In Japan, vaccination was first introduced in February 2021. However, the amount of concern towards vaccination differs between individuals, and topics of concern include adverse reactions and side effects. This study investigated attitudes toward vaccines or vaccination during the COVID-19 pandemic across different Japanese prefectures, using Yahoo! JAPAN search queries. We first defined a vaccine concern index (VCI) by aggregating the search counts of vaccine-related queries from Yahoo! JAPAN users before examining VCI across all Japanese prefectures, accounting for gender and age. Our results demonstrated that VCI tended to be lower in more populated areas, and VCI was higher in their 20s to 40s than older people, especially in female users. Furthermore, there was a significant positive correlation (Spearman's Rank correlation coefficient [Formula: see text] = 0.60, [Formula: see text]) between VCI and prefectural vaccination rate, suggesting that web searching of adverse vaccine reactions may precede actual vaccination. This could reflect the information-seeking behavior of individuals who are accepting of vaccinations.

Indexed as

COVID-19VaccinesAgedCOVID-19 VaccinesFemaleHumansInternetJapanPandemicsVaccinationCOVID-19 VaccinesVaccines

Identifiers

PMID36057657
PMCPMC9440921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.